Home
Conference
Sponsors
Educational Resources
Contact
Subscribe
More...
Tracking Disease Activity and Treatment Response in IBD: Biomarkers and Wearables
Will Someone Define What Is Moderate to Severe Disease?
Playing JAKs: Right Patient, Right Time, Right Dose
Will AI Change Our Approach to Mucosal Healing?
How "I" Select First-Line Advanced Therapies for Moderate-Severe Ulcerative Colitis
Combining Therapies for IBD: Rationale and Practical Aspects
Current & Future Utility of Intestinal Ultrasound for Disease Monitoring
Selecting First Line Advanced Therapy in Crohn's Disease
FDA Endpoints in Gastroparesis
When It's Not...The IBS-D Mimickers
Update on C. difficile
Novel Capsule Technologies for DGBI and Motility Disorders
Eosinophilic GI Diseases
Microbiome-Based Therapies?
Novel Breath Testing Technologies
Management of Helicobacter pylori in North America
Updates on Treatment of IBS-C and CIC